@oncodaily.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

OncoDaily

oncodaily.bsky.social

did:plc:ulozjjf5jrge3s4yr7luulgu

Promising cCR Rates in VICEROY Phase 1/2 FLT3m AML Study - Talha Badar @talhabadarmd.bsky.social oncodaily.com/voices/425957 #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews https://oncodaily.com/voices/425957

2025-12-11T13:37:43.195Z